Susana Otero-Romero
Overview
Explore the profile of Susana Otero-Romero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
924
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vaccination in multiple sclerosis: Tackling challenges and paving the way for effective immunization
Carvajal R, Tur C, Borras-Bermejo B, Saylor D, Montalban X, Tintore M, et al.
Mult Scler
. 2025 Mar;
:13524585251318513.
PMID: 40071952
Background: Vaccination in patients with multiple sclerosis (PwMS) presents unique challenges. Disease-modifying therapies (DMTs) can increase infectious risks, though these are largely preventable through immunizations. However, DMTs can also reduce...
2.
Wyndham-Thomas C, Newbern E, Mira-Iglesias A, Dwivedi A, Orrico Sanchez A, Anton A, et al.
J Infect Public Health
. 2025 Feb;
18(5):102700.
PMID: 40014936
Background: JCOVDEN (Ad26.COV2.S), a viral-vector vaccine, was granted conditional marketing authorisation in the European Union for the prevention of COVID-19 in early 2021. We present JCOVDEN single-dose vaccine effectiveness (VE)...
3.
Vilaseca A, Tintore M, Carbonell-Mirabent P, Rodriguez-Barranco M, Arevalo M, Arino H, et al.
Mult Scler
. 2025 Feb;
:13524585251314749.
PMID: 39907218
Background: It is essential to exclude alternative diagnoses to diagnose multiple sclerosis (MS). However, detailed descriptions of alternative diagnoses in patients with suspected MS presenting with clinically isolated syndrome (CIS)...
4.
Cobo-Calvo A, Carbonell-Mirabent P, Tur C, Otero-Romero S, Carvajal R, Arrambide G, et al.
Neurology
. 2025 Feb;
104(4):e210305.
PMID: 39903901
Background And Objectives: Emerging concepts in the early detection of multiple sclerosis (MS) progression reveal that disability accumulation can start early in the disease course. Aging in MS is increasingly...
5.
de Munter L, Meeraus W, Dwivedi A, Mitratza M, Wyndham-Thomas C, Carty L, et al.
Eur J Public Health
. 2025 Jan;
PMID: 39836896
Marketing authorization holders of vaccines typically need to report brand-specific vaccine effectiveness (VE) to the regulatory authorities as part of their regulatory obligations. COVIDRIVE (now id. DRIVE) is a European...
6.
Carvajal R, Guananga-Alvarez D, Tur C, Esperalba J, Rodriguez-Barranco M, Rando-Segura A, et al.
Neurology
. 2025 Jan;
104(3):e210281.
PMID: 39819099
Background And Objectives: Hepatitis B vaccination (HBV) requires 6 months to complete and is recommended for patients with multiple sclerosis (PWMS), particularly those who are candidates for anti-CD20 therapy. However,...
7.
Nguyen J, Mitratza M, Volkman H, de Munter L, Tran T, Marques C, et al.
EClinicalMedicine
. 2024 Dec;
79:102995.
PMID: 39726669
Background: Prior studies have reported lower effectiveness of XBB.1.5-adapted vaccines against hospitalization related to the Omicron JN.1 variant than the XBB variant. This study evaluated the effectiveness and durability of...
8.
Carvajal R, Rodriguez-Acevedo B, Garcia-Vasco L, Zabalza A, Arino H, Bollo L, et al.
Mult Scler
. 2024 Nov;
30(14):1788-1801.
PMID: 39520297
Background: Organizing pneumonia (OP), an interstitial lung disease, has been observed in patients with inflammatory demyelinating diseases (IDDs) treated with anti-CD20, particularly after COVID-19, but data are limited. Aim: To...
9.
Tur C, Carvajal R, Otero-Romero S, Tintore M
Neurology
. 2024 Jul;
103(3):e209730.
PMID: 39018517
No abstract available.
10.
Carvajal R, Zabalza A, Carbonell-Mirabent P, Martinez-Gomez X, Esperalba J, Pappolla A, et al.
JAMA Netw Open
. 2024 Apr;
7(4):e246345.
PMID: 38607624
Importance: Vaccination in patients with highly active multiple sclerosis (MS) requiring prompt treatment initiation may result in impaired vaccine responses and/or treatment delay. Objective: To assess the immunogenicity and safety...